Hot Performing Stocks To Watch Right Now

The major U.S. stock indices posted another negative weekly close last week, led lower by the small-cap Russell 2000, which lost 1.4% and is now down 1.9% for 2016. The tech-heavy Nasdaq 100, another perennial market leader, fell 0.3% and is down 5.7% for the year.

The market is at an important near-term decision point. Stocks must quickly and aggressively resume their advance or risk slipping into a deeper decline.

The two hardest hit sectors last week were energy (-3.3%) and financial services (-2.5%), while real estate was the best-performing sector (+3.7%). The movement in the latter two was driven by falling long-term interest rates.

Despite weakness in energy, the table below shows that the biggest positive percentage change in sector bet-related assets over the past one-month and three-month periods were into this sector. As long as these positive asset flows continue, energy stocks still have the potential to move significantly higher in the weeks and months ahead.

Hot Performing Stocks To Watch Right Now: Sarepta Therapeutics, Inc.(SRPT)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Skorney’s namesVertex Pharmaceuticals (VRTX),Sarepta Therapeutics (SRPT), and Curis (CRIS) his top biotech picks for 2017, while Ulz chosesBioMarin Pharmaceutical (BMRN) andParatek Pharmaceuticals (PRTK).

  • [By Ben Levisohn]

    After surveying 30 neurologists, Baird’s Brian Skorney and Neena Bitritto-Garg contend that the Street might be underestimating sales of Sarepta Therapeutics (SRPT) Exondys 51 treatment for patients with Duchenne muscular dystrophy. They explain why:

  • [By Chris Lange]

    Sarepta Therapeutics, Inc. (NASDAQ: SRPT) saw its shares make a handy gain on Tuesday following its presentation at the JPMorgan Healthcare Conference. The companys Duchenne muscular dystrophy (DMD) drug, Exondys 51, generated better than expected sales clocking in at $5.4 million in the fourth quarter. Previously, this DMD treatment was approved by the FDA just as recently as September 2016.

  • [By Lisa Levin]

    Sarepta Therapeutics Inc (NASDAQ: SRPT) shares were also up, gaining 16 percent to $47.52 following the announcement of positive results in its study for the treatment of Duchenne Muscular Dystrophy.

  • [By Johanna Bennett]

    Will healthinsurers pay for Sarepta Therapeutics (SRPT) Exondys 51?

    Thats a question that several analysts have weighed on today. It appears that payors are still actively evaluating and reevaluating coverage of the Duchenne muscular dystrophy drug Exondys 51.

    Approved by the FDA in September, the drug has met with widespread pushback from insurers like Anthem (ANTM), Humana (HUM) and UnitedHealth Group (UNH) amid concerns about its efficacy. So while Sareptas share price has more than doubled over the past 12 months, it has made a sharp retreat, falling 50% to just under $32 a share since hitting a record high $63.73 a share in late September.

    But Cowen analyst Ritu Baral says the tide maybe turning, arguing that coverage denials wont be permanent.

    As SRPT management and our Neuromuscular Disease panelist indicated to us at our recent Healthcare Conference, payor discussions are continuing regarding Exondys 51 with manageable, increasingly positive feedback. Of the major plans we have seen coverage policies released for, only Anthem (including Blue Cross Blue Shield) had previously denied coverage of Exondys, though patients could petition for coverage via a standard appeal process (see further below). Based on their February Specialty Pharmacy Medical Management Prior Authorization Drug List, it appears Anthem will add Exondys 51 to its prior auth list as of 5/1. We think this is encouraging and indicative of the evolving payor landscape surrounding Exondys 51 and more broadly, DMD. Anthem’s pick-up, together with those such as United, which started coverage on 2/1, support the idea of accelerating new patient starts, suggested by SRPT last week at our Healthcare Conference.

    …But Coverage Denials Persist (For Now), Especially Among Non-Ambulatory Patients. While we think the overwhelming majority of amenable patients will eventually be covered for Exondys 51, we do note several social media anecdote

Hot Performing Stocks To Watch Right Now: Turkcell Iletisim Hizmetleri AS(TKC)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, telecommunications services shares slipped by 0.08 percent. Meanwhile, top losers in the sector included Turkcell Iletisim Hizmetleri A.S. (ADR) (NYSE: TKC), down 2 percent, and Telefonica Brasil SA (ADR) (NYSE: VIV), down 2.5 percent.

Hot Performing Stocks To Watch Right Now: Endeavour Silver Corporation(EXK)

Advisors’ Opinion:

  • [By Manikandan Raman]

    Citing bullish outlook on silver prices, Peter Bures of Canaccord Genuity has started coverage of four silver producers: Pan American Silver Corp. (USA) (NASDAQ: PAAS), Coeur Mining Inc (NYSE: CDE), Hecla Mining Company (NYSE: HL), and Endeavour Silver Corp (NYSE: EXK). The brokerage also assumed coverage of Fortuna Silver Mines Inc (NYSE: FSM) with a Buy rating.

  • [By Lisa Levin]

    On Monday, basic materials shares surged by 1.1 percent. Top gainers in the sector included Cliffs Natural Resources Inc (NYSE: CLF) and Endeavour Silver Corp (NYSE: EXK).

  • [By Lisa Levin]

    In trading on Thursday, basic materials shares fell by 1.66 percent. Meanwhile, top losers in the sector included Endeavour Silver Corp (NYSE: EXK), down 22 percent, and Greif, Inc. (NYSE: GEF), down 10 percent.

  • [By Lisa Levin]

    Tuesday afternoon, the basic materials sector proved to be a source of strength for the market. Leading the sector was strength from Endeavour Silver Corp (NYSE: EXK) and DRDGOLD Ltd. (ADR) (NYSE: DRD).

Hot Performing Stocks To Watch Right Now: Cresud S.A.C.I.F. y A.(CRESY)

Advisors’ Opinion:

  • [By Cameron Swinehart]

    Cresud (CRESY) –

    An Argentinean based agriculture company that currently owns roughly 2.4 million acres of farmland in Argentina, Brazil, Paraguay and Bolivia. CRESY produces a variety of crops consisting of soybeans, corn, and sugarcane. It also has operations in beef cattle and milk production. In the second quarter, Cresud sold 4 of its farms for roughly $60.5 million and saw large gains in its farmland development business. CRESY is currently trading down roughly 60% from its highs back in late 2010. Many farming companies have struggled to release value for shareholders with the drop in crop prices but now many are beginning to see value with the sale of farmland.

Hot Performing Stocks To Watch Right Now: Telecom Argentina Stet – France Telecom S.A.(TEO)

Advisors’ Opinion:

  • [By Jim Robertson]

    Yesterday, our Under the Radar Moversportfolio newsletter suggested small cap telecommunications Telecom Argentina SA (NYSE: TEO) as a short/bearish trade:

  • [By Lisa Levin]

    Wednesday afternoon, the telecommunications services sector proved to be a source of strength for the market. Leading the sector was strength from Consolidated Communications Holdings Inc (NASDAQ: CNSL) and Telecom Argentina SA (ADR) (NYSE: TEO).

Hot Performing Stocks To Watch Right Now: CNX Coal Resources LP(CNXC)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Well, the time to start buying would have been last February–when everything started rallying. Since February 11, 2016, shares of Alliance Resource Partners (ARLP) have doubled, while Cloud Peak Energy (CLD) and CNX Coal Resources (CNXC) have tripled. Of course, Peabody Energy was fast approaching bankruptcy then, so missed out on that amazing run.

Leave a Reply

Your email address will not be published. Required fields are marked *